Original document(12 pages)  中文版
    The invention relates to the derivatives and the salts having a general formula (I) and (II), wherein R1 is low level alkyl or halogen atom substituted low level alkyl, R2 is C1-4 straight chain or branched chain alkyl, R3 represents hydrogen, Li, Na or K.
Application Number
申请号		 200410037985 Application Date
申请日		 2004.05.14
Title 名称 Razole derivatives and application thereof
Publication Number
公开号		 1803793 Publication Date
公开日		 2006.07.19
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D401/12,C07D471/04,A61K31/4439,A61P31/04,A61P1/04,C07D213/68,C07D235/28
Applicant(s) Name
申请人		 Jiangsu Haosen Pharmaceutical Ltd.
Address 地址
Inventor(s) Name 发明人 Zhong Huijuan
Attorney & Agent 代理人 cheng wei

  
Method for preparing olanzapine
Oral ofloxacin control-sustained releasing medicinal composition
Oral ofloxacin control-sustained releasing medicinal composition
Ammonia maleate rubicin salt, and its preparing method and use
Steroid derivatives
Polyethylene glycol-modified thymus peptide 1 derivatives
Ambroxol cysteine analogs and their preparation process and use thereof
Imidazole derivative compound, its salts and use thereof
Process for preparing razole series heterocyclic compound and salts thereof
Method for preparing Repaglinide
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.